Annexon, Inc. (ANNX)
3.92
-0.05
(-1.26%)
USD |
NASDAQ |
Nov 13, 16:00
3.93
+0.01
(+0.26%)
After-Hours: 19:59
Annexon Price to Book Value : 5.218 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.218 |
| November 12, 2026 | 5.285 |
| November 11, 2026 | 5.578 |
| November 10, 2026 | 5.604 |
| November 09, 2026 | 5.631 |
| November 06, 2026 | 5.591 |
| November 05, 2026 | 5.332 |
| November 04, 2026 | 5.764 |
| November 03, 2026 | 5.578 |
| November 02, 2026 | 5.245 |
| October 30, 2026 | 5.391 |
| October 29, 2026 | 5.338 |
| October 28, 2026 | 5.378 |
| October 27, 2026 | 5.005 |
| October 26, 2026 | 4.926 |
| October 23, 2026 | 4.992 |
| October 22, 2026 | 5.072 |
| October 21, 2026 | 5.138 |
| October 20, 2026 | 5.099 |
| October 19, 2026 | 5.338 |
| October 16, 2026 | 4.540 |
| October 15, 2026 | 4.792 |
| October 14, 2026 | 4.886 |
| October 13, 2026 | 5.099 |
| October 12, 2026 | 5.272 |
| Date | Value |
|---|---|
| October 09, 2026 | 5.352 |
| October 08, 2026 | 5.325 |
| October 07, 2026 | 5.338 |
| October 06, 2026 | 5.365 |
| October 05, 2026 | 5.591 |
| October 02, 2026 | 5.578 |
| October 01, 2026 | 5.485 |
| September 30, 2026 | 5.631 |
| September 29, 2026 | 3.876 |
| September 28, 2026 | 3.763 |
| September 25, 2026 | 3.416 |
| September 24, 2026 | 3.566 |
| September 23, 2026 | 3.632 |
| September 22, 2026 | 3.923 |
| September 21, 2026 | 3.960 |
| September 18, 2026 | 3.970 |
| September 17, 2026 | 3.913 |
| September 16, 2026 | 3.688 |
| September 15, 2026 | 3.679 |
| September 14, 2026 | 3.707 |
| September 11, 2026 | 3.697 |
| September 10, 2026 | 3.885 |
| September 09, 2026 | 4.101 |
| September 08, 2026 | 4.382 |
| September 04, 2026 | 4.570 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.335 |
| Alnylam Pharmaceuticals, Inc. | 6.131 |
| Anika Therapeutics, Inc. | 1.305 |
| Savara, Inc. | 8.843 |
| Arrowhead Pharmaceuticals, Inc. | 134.18 |
Price to Book Value Related Metrics
| Price | 3.92 |
| Earnings Yield | -26.26% |
| Market Cap | 745.16M |